about
Prefrontal gray matter volume mediates age effects on memory strategiesFrequency analysis of the visual steady-state response measured with the fast optical signal in younger and older adultsTau and Aβ imaging, CSF measures, and cognition in Alzheimer's diseaseThe effects of white matter hyperintensities and amyloid deposition on Alzheimer dementiaCerebral amyloidosis associated with cognitive decline in autosomal dominant Alzheimer diseaseA diffusion model analysis of episodic recognition in preclinical individuals with a family history for Alzheimer's disease: The adult children study.Evidence for a detrimental relationship between hypertension history, prospective memory, and prefrontal cortex white matter in cognitively normal older adults.Comparing Aging and Fitness Effects on Brain Anatomy.Neuroanatomical correlates of aging, cardiopulmonary fitness level, and educationAV-1451 PET imaging of tau pathology in preclinical Alzheimer disease: Defining a summary measure.Regional variability in Alzheimer's disease biomarkers.Effects of measurement method, wavelength, and source-detector distance on the fast optical signal.Spread of activation and deactivation in the brain: does age matter?Clinical, imaging, pathological, and biochemical characterization of a novel presenilin 1 mutation (N135Y) causing Alzheimer's disease.Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry.Left caudal middle frontal gray matter volume mediates the effect of age on self-initiated elaborative encoding strategies.Tau and Amyloid Positron Emission Tomography Imaging Predict Driving Performance Among Older Adults with and without Preclinical Alzheimer's Disease.In vivo [18F]-AV-1451 tau-PET imaging in sporadic Creutzfeldt-Jakob disease.Tau-PET Binding Distinguishes Patients With Early-stage Posterior Cortical Atrophy From Amnestic Alzheimer Disease Dementia.Aerobic glycolysis and tau deposition in preclinical Alzheimer's disease.Alzheimer disease biomarkers and synucleinopathy.Cross-sectional and longitudinal atrophy is preferentially associated with tau rather than amyloid β positron emission tomography pathology.Longitudinal cognitive and biomarker changes in dominantly inherited Alzheimer diseaseWidespread distribution of tauopathy in preclinical Alzheimer's diseaseTau Kinetics in Neurons and the Human Central Nervous SystemUtility of perfusion PET measures to assess neuronal injury in Alzheimer's diseaseSerum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s diseaseComparison of Pittsburgh compound B and florbetapir in cross-sectional and longitudinal studiesMeasures of metabolism provide insights into hippocampal sclerosisTau Kinetics in Neurons and the Human Central Nervous SystemLoss of white matter integrity reflects tau accumulation in Alzheimer disease defined regionsA soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer's diseaseDiscovery and validation of autosomal dominant Alzheimer's disease mutationsElevated tau PET signal depends on abnormal amyloid levels and is uncommon in unimpaired individualsEffect of apolipoprotein E4 on clinical, neuroimaging, and biomarker measures in noncarrier participants in the Dominantly Inherited Alzheimer NetworkUtilizing the Centiloid scale in cross-sectional and longitudinal PiB PET studiesInfluence of tau PET, amyloid PET, and hippocampal volume on cognition in Alzheimer diseaseAssessment of Racial Disparities in Biomarkers for Alzheimer DiseaseAuthor response: In vivo [18F]-AV-1451 tau-PET imaging in sporadic Creutzfeldt-Jakob diseaseTau PET in autosomal dominant Alzheimer's disease: relationship with cognition, dementia and other biomarkers
P50
Q33974799-83D303ED-43A2-4C88-8B56-9EDA4E3426E4Q34037227-ABE35F99-E8D3-4114-8260-C8888843F1A1Q34526181-2361A616-9915-4BC0-9BD4-8C187689774AQ35760152-3BBEC699-0D04-4DEE-90C8-5C89E0068927Q36005633-799E53F8-3E10-497A-AD18-360A4E63B654Q36484068-F7881451-47C2-48D1-85BF-DA1AE7E14D8BQ36788248-5BEADC86-83B0-4B23-9292-8342E5673274Q37043151-31C37DE8-2737-42D8-AC52-E884FC28E441Q37619221-1A2869CF-A1C6-4716-BCE3-B7CFA7ECFFC0Q38653494-ABA352B0-51EC-490A-B4BE-324DB1BC21F9Q39114387-5510875C-4428-4849-AEA3-2AEF966D76F3Q42692972-506B5948-46E7-4883-9268-8F9A973E8182Q42946886-581260BA-4390-4F9B-BC9E-AFFFD9B3E396Q47104398-72A15935-27EA-40DF-850B-B8862C16706EQ47587631-4A32708C-27F5-41D4-9BB5-08DAAACCAD61Q48638136-5D7E374D-51C1-4329-92A5-124314244CD8Q49678393-C6318E3E-E58A-4360-83E9-8E612F56B544Q50042841-54938F1C-5FD7-495B-AC88-8E59EEBA2DB7Q51064883-6AF23DDE-FBC4-449B-BF1B-7B0ACCADDB0AQ53397162-62E08066-B84C-4CFC-AB3D-2AF1B1E6DB6EQ53512226-27074AD7-3D25-4C4D-ABB4-F86062A89700Q55003313-587E0BC7-C66A-4572-9977-DA17E3A5B3F2Q57049035-2BC6E641-7AB3-4FB6-866B-A5C64FD814FAQ57192742-1458BE51-DA17-4B45-B89B-2050EF4B901FQ57215461-43955BD6-F694-4B91-AE8D-9E37CA5EED16Q59126759-DEAA783F-B230-4D04-A6D9-77D2134EE024Q60961744-C9D3AE8B-1363-4EAC-A6E8-32148C6E9EA9Q64109135-E792FCBF-DEA0-4F17-8EFD-66706EB2039CQ88215259-3CA20009-1DA7-447B-AE27-9CA460AB4F1FQ88716750-86FC1C9A-3534-4081-B4C1-189E87B363C7Q89356348-A407BE62-E305-4B07-A500-A258F3A37B20Q90246734-316F5FDB-A4C1-46C0-A8C7-6C85CC9DED8DQ90319672-554A198F-B981-4527-B95C-11503D778B73Q90325474-989A7777-090A-4922-A32E-545DE9A9070CQ90362067-5ED21A8F-8F1A-448F-AB0F-E89DB557D529Q90406450-341307CB-BFCA-4F43-9A44-5C5AD7DA53D2Q90697133-83A15339-11BD-4A4D-B387-5DAA2DD3DE9DQ90918941-1E652CAB-21F8-4D5E-BA82-1C58A5A8D8E4Q91044819-3C193152-3805-4C76-881B-34D90D3778ACQ91501353-660AF82A-875F-4C4E-A607-DB8718D7563B
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Brian A Gordon
@ast
Brian A Gordon
@en
Brian A Gordon
@es
Brian A Gordon
@nl
type
label
Brian A Gordon
@ast
Brian A Gordon
@en
Brian A Gordon
@es
Brian A Gordon
@nl
altLabel
Gordon BA
@en
prefLabel
Brian A Gordon
@ast
Brian A Gordon
@en
Brian A Gordon
@es
Brian A Gordon
@nl
P106
P1153
36862511300
P2456
P31
P496
0000-0003-2109-2955